<?xml version="1.0" encoding="UTF-8"?>
<ref id="B31">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>De Felice</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Annunziata</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Fiorentino</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Borra</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Biffali</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Coppola</surname>
    <given-names>C.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2014</year>). 
  <article-title>miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.</article-title>
  <source>
   <italic>Neurogenetics</italic>
  </source>
  <volume>15</volume>
  <fpage>243</fpage>â€“
  <lpage>253</lpage>. 
  <pub-id pub-id-type="doi">10.1007/s10048-014-0420-2</pub-id>
  <?supplied-pmid 25130371?>
  <pub-id pub-id-type="pmid">25130371</pub-id>
 </mixed-citation>
</ref>
